Repository logo
 
Publication

Clinical performance of an infliximab rapid quantification assay

dc.contributor.authorMagro, F.
dc.contributor.authorAfonso, J.
dc.contributor.authorLopes, S.
dc.contributor.authorCoelho, R.
dc.contributor.authorGonçalves, R.
dc.contributor.authorCaldeira, P.
dc.contributor.authorLago, P.
dc.contributor.authorSousa, H.
dc.contributor.authorRamos, J.
dc.contributor.authorGonçalves, A.
dc.contributor.authorMinistro, P.
dc.contributor.authorRosa, I.
dc.contributor.authorMeira, T.
dc.contributor.authorAndrade, P.
dc.contributor.authorSoares, J.
dc.contributor.authorCarvalho, D.
dc.contributor.authorSousa, P.
dc.contributor.authorVieira, A.
dc.contributor.authorLopes, J.
dc.contributor.authorDias, C.
dc.contributor.authorGeboes, K.
dc.contributor.authorCarneiro, F.
dc.date.accessioned2018-10-25T14:40:48Z
dc.date.available2018-10-25T14:40:48Z
dc.date.issued2017-09
dc.description.abstractBACKGROUND: Therapeutic drug monitoring (TDM)-based algorithms can be used to guide infliximab (IFX) adjustments in inflammatory bowel disease (IBD) patients. This study aimed to explore a rapid IFX-quantification test from a clinical perspective. METHODS: This manuscript describes a prospective cohort study involving 110 ulcerative colitis (UC) patients on the maintenance phase of IFX. IFX trough levels were quantified using a rapid quantification assay and a commonly-used reference kit. RESULTS: Irrespective of the assay used to measure IFX, its through levels were statistically different between patients with and without endoscopic remission (Mayo endoscopic score = 0), as well as between patients stratified by their faecal calprotectin (FC) levels. Despite the fact that the two methods correlated well with each other [Spearman's rank correlation coefficient = 0.843, p < 0.001; intraclass correlation coefficients = 0.857, 95% confidence interval (CI): 0.791-0.903], there was a discernible systematic variation; values obtained with the reference kit were on average 2.62 units higher than those obtained with the rapid assay. Notwithstanding, 3 µg/ml was shown to be an acceptable cut-off to assess endoscopic status and inflammatory burden levels using both assays. The percentage of patients that had a positive outcome when the IFX concentration measured by the rapid assay ranked above 3 µg/ml was 88% both for a Mayo endoscopic score ⩽ 1 and for an FC concentration <250 µg/g. CONCLUSIONS: Based on this study, we concluded that using the rapid IFX assessment system with a 3 µg/ml threshold is a reliable alternative to the time-consuming enzyme-linked immunosorbent assays in patients on the maintenance phase of IFX.pt_PT
dc.description.sponsorshipThis work was supported by the Portuguese IBD Group (GEDII, Grupo de Estudo da Doença Inflamatória Intestinal)pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationTherap Adv Gastroenterol. 2017 Sep;10(9):651-660pt_PT
dc.identifier.doi10.1177/1756283X17722916pt_PT
dc.identifier.issn1756-283X
dc.identifier.issn1756-2848
dc.identifier.urihttp://hdl.handle.net/10400.16/2235
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSAGE Publicationspt_PT
dc.relation.publisherversionhttp://journals.sagepub.com/doi/abs/10.1177/1756283X17722916?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&pt_PT
dc.subjectinfliximabpt_PT
dc.subjecttherapeutic windowpt_PT
dc.subjectulcerative colitispt_PT
dc.titleClinical performance of an infliximab rapid quantification assaypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceEnglandpt_PT
oaire.citation.endPage660pt_PT
oaire.citation.issue9pt_PT
oaire.citation.startPage651pt_PT
oaire.citation.titleTherapeutic Advances in Gastroenterologypt_PT
oaire.citation.volume10pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Clinical performance of an infliximab rapid.pdf
Size:
265.51 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.35 KB
Format:
Item-specific license agreed upon to submission
Description: